180 related articles for article (PubMed ID: 19735074)
1. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
2. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
4. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein.
Higgins LM; McDonald SA; Whittle N; Crockett N; Shields JG; MacDonald TT
J Immunol; 1999 Jan; 162(1):486-93. PubMed ID: 9886424
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
6. Augmented antitumor activity of a secondary lymphoid-tissue chemokine (SLC)-interleukin (IL) 2 fusion protein in mouse.
Nakahara K; Sakata T
J Gene Med; 2003 Jun; 5(6):463-71. PubMed ID: 12797111
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.
Kiyokawa T; Shirono K; Hattori T; Nishimura H; Yamaguchi K; Nichols JC; Strom TB; Murphy JR; Takatsuki K
Cancer Res; 1989 Jul; 49(14):4042-6. PubMed ID: 2786749
[TBL] [Abstract][Full Text] [Related]
8. [Expression of IL-2 receptors on the surfaces of L1210 cells and bioactivity assay for IL-2-toxin fusion proteins].
Zhang L; Nie L; Li H; Li S; Lu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):344-7. PubMed ID: 12903447
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice.
Black JH; McCubrey JA; Willingham MC; Ramage J; Hogge DE; Frankel AE
Leukemia; 2003 Jan; 17(1):155-9. PubMed ID: 12529673
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.
Waters CA; Schimke PA; Snider CE; Itoh K; Smith KA; Nichols JC; Strom TB; Murphy JR
Eur J Immunol; 1990 Apr; 20(4):785-91. PubMed ID: 2140788
[TBL] [Abstract][Full Text] [Related]
11. Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.
Hogge DE; Yalcintepe L; Wong SH; Gerhard B; Frankel AE
Clin Cancer Res; 2006 Feb; 12(4):1284-91. PubMed ID: 16489085
[TBL] [Abstract][Full Text] [Related]
12. Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human disease.
Murphy JR; Lakkis FG; vanderSpek JC; Anderson P; Strom TB
Targeted Diagn Ther; 1992; 7():365-82. PubMed ID: 1633299
[No Abstract] [Full Text] [Related]
13. A novel design of targeted endocrine and cytokine therapy for breast cancer.
Zhang G; Li W; Holle L; Chen N; Chen WY
Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
[TBL] [Abstract][Full Text] [Related]
14. [Design and expression of a diphtheria toxin hybrid protein and human interleukin-2 gene in Escherichia coli].
Shemiakin IG; Anisimova VA; Mitrofanova GN
Mol Biol (Mosk); 1992; 26(5):1088-98. PubMed ID: 1470175
[TBL] [Abstract][Full Text] [Related]
15. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
[TBL] [Abstract][Full Text] [Related]
16. rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease.
Byrne FR; Farrell CL; Aranda R; Rex KL; Scully S; Brown HL; Flores SA; Gu LH; Danilenko DM; Lacey DL; Ziegler TR; Senaldi G
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G690-701. PubMed ID: 11897629
[TBL] [Abstract][Full Text] [Related]
17. Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies.
Williams MD; Rostovtsev A; Narla RK; Uckun FM
Protein Expr Purif; 1998 Jul; 13(2):210-21. PubMed ID: 9675065
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.
Boehm F; Martin M; Kesselring R; Schiechl G; Geissler EK; Schlitt HJ; Fichtner-Feigl S
BMC Gastroenterol; 2012 Jul; 12():97. PubMed ID: 22849659
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis.
van der Marel S; Majowicz A; Kwikkers K; van Logtenstein R; te Velde AA; De Groot AS; Meijer SL; van Deventer SJ; Petry H; Hommes DW; Ferreira V
World J Gastroenterol; 2012 Aug; 18(32):4288-99. PubMed ID: 22969191
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.
Kunzendorf U; Pohl T; Bulfone-Paus S; Krause H; Notter M; Onu A; Walz G; Diamantstein T
J Clin Invest; 1996 Mar; 97(5):1204-10. PubMed ID: 8636431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
